These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 8778165)

  • 1. Modifications of biochemical markers of bone and collagen turnover during corticosteroid therapy.
    Conti A; Sartorio A; Ferrero S; Ferrario S; Ambrosi B
    J Endocrinol Invest; 1996 Feb; 19(2):127-30. PubMed ID: 8778165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New markers of bone and collagen turnover in children and adults with growth hormone deficiency.
    Sartorio A; Conti A; Monzani M
    Postgrad Med J; 1993 Nov; 69(817):846-50. PubMed ID: 8290428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of GH/IGF-I deficiency on bone and collagen turnover in children and adults with GH deficiency].
    Sartorio A; Conti A; Monzani M; Ferrero S; Biella O; Casati G; Faglia G
    Minerva Endocrinol; 1995 Jun; 20(2):135-40. PubMed ID: 8531895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone treatment in adults with GH deficiency: effects on new biochemical markers of bone and collagen turnover.
    Sartorio A; Conti A; Monzani M; Morabito F; Faglia G
    J Endocrinol Invest; 1993 Dec; 16(11):893-8. PubMed ID: 8144866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of 12 months rec-GH therapy on bone and collagen turnover and bone mineral density in GH deficient children with thalassaemia major.
    Sartorio A; Conte G; Conti A; Masala A; Alagna S; Rovasio P; Faglia G
    J Endocrinol Invest; 2000 Jun; 23(6):356-61. PubMed ID: 10908162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis.
    Guañabens N; Parés A; Alvarez L; Martínez de Osaba MJ; Monegal A; Peris P; Ballesta AM; Rodés J
    J Bone Miner Res; 1998 Apr; 13(4):731-8. PubMed ID: 9580479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of markers of bone and collagen turnover in patients with active and preclinical Cushing's syndrome and in patients with adrenal incidentaloma.
    Sartorio A; Conti A; Ferrero S; Giambona S; Re T; Passini E; Ambrosi B
    Eur J Endocrinol; 1998 Feb; 138(2):146-52. PubMed ID: 9506857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How useful are bone turnover markers in rheumatoid arthritis? Influence of disease activity and corticosteroid therapy.
    Cortet B; Flipo RM; Pigny P; Duquesnoy B; Racadot A; Boersma A; Delcambre B
    Rev Rhum Engl Ed; 1997 Mar; 64(3):153-9. PubMed ID: 9090763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-dependent effects of recombinant human growth hormone on biochemical markers of bone and collagen metabolism in adult growth hormone deficiency.
    Bollerslev J; Møller J; Thomas S; Djøseland O; Christiansen JS
    Eur J Endocrinol; 1996 Dec; 135(6):666-71. PubMed ID: 9025710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 12 months rhGH treatment on bone and collagen turnover in children with constitutional growth delay.
    Sartorio A; Conti A; Ferrero S; Saraifoger S; Resnik M; Baroncelli GI
    J Pediatr Endocrinol Metab; 1999; 12(6):833-8. PubMed ID: 10614540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elite volunteer athletes of different sport disciplines may have elevated baseline GH levels divorced from unaltered levels of both IGF-I and GH-dependent bone and collagen markers: a study on-the-field.
    Sartorio A; Marazzi N; Agosti F; Faglia G; Corradini C; De Palo E; Cella S; Rigamonti A; Muller EE
    J Endocrinol Invest; 2004 May; 27(5):410-5. PubMed ID: 15279071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal bone turnover in monoclonal gammopathy of undetermined significance: analyses of type I collagen telopeptide, osteocalcin, bone-specific alkaline phosphatase and propeptides of type I and type III procollagens.
    Vejlgaard T; Abildgaard N; Jans H; Nielsen JL; Heickendorff L
    Eur J Haematol; 1997 Feb; 58(2):104-8. PubMed ID: 9111591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 12-month GH treatment on bone metabolism and bone mineral density in adults with adult-onset GH deficiency.
    Sartorio A; Ortolani S; Galbiati E; Conte G; Vangeli V; Arosio M; Porretti S; Faglia G
    J Endocrinol Invest; 2001 Apr; 24(4):224-30. PubMed ID: 11383908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical markers of bone and collagen turnover in acromegaly or Cushing's syndrome.
    Piovesan A; Terzolo M; Reimondo G; Pia A; Codegone A; Osella G; Boccuzzi A; Paccotti P; Angeli A
    Horm Metab Res; 1994 May; 26(5):234-7. PubMed ID: 8076906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum markers of bone metabolism in multiple myeloma: prognostic value of the carboxy-terminal telopeptide of type I collagen (ICTP). Nordic Myeloma Study Group (NMSG).
    Abildgaard N; Bentzen SM; Nielsen JL; Heickendorff L
    Br J Haematol; 1997 Jan; 96(1):103-10. PubMed ID: 9012695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term monitoring of rec-GH treatment by serial determination of serum aminoterminal propeptide of type III procollagen in children and adults with GH deficiency.
    Sartorio A; Arosio M; Conti A; Ferrero S; Porretti S; Faglia G
    J Endocrinol Invest; 1999 Mar; 22(3):169-75. PubMed ID: 10219883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in (markers of) bone metabolism during high dose corticosteroid pulse treatment in patients with rheumatoid arthritis.
    Lems WF; Gerrits MI; Jacobs JW; van Vugt RM; van Rijn HJ; Bijlsma JW
    Ann Rheum Dis; 1996 May; 55(5):288-93. PubMed ID: 8660101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum markers of bone and collagen turnover in patients with Cushing's syndrome and in subjects with adrenal incidentalomas.
    Osella G; Terzolo M; Reimondo G; Piovesan A; Pia A; Termine A; Paccotti P; Angeli A
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3303-7. PubMed ID: 9329358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of two years of growth hormone (GH) replacement therapy on bone metabolism and mineral density in childhood and adulthood onset GH deficient patients.
    Longobardi S; Di Rella F; Pivonello R; Di Somma C; Klain M; Maurelli L; Scarpa R; Colao A; Merola B; Lombardi G
    J Endocrinol Invest; 1999 May; 22(5):333-9. PubMed ID: 10401706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor-I raises serum procollagen levels in children and adults with Laron syndrome.
    Klinger B; Jensen LT; Silbergeld A; Laron Z
    Clin Endocrinol (Oxf); 1996 Oct; 45(4):423-9. PubMed ID: 8959080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.